Serveur d'exploration SRAS

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Pulmonary pathology of severe acute respiratory syndrome in Toronto.

Identifieur interne : 002560 ( PubMed/Checkpoint ); précédent : 002559; suivant : 002561

Pulmonary pathology of severe acute respiratory syndrome in Toronto.

Auteurs : David M. Hwang [Canada] ; Dean W. Chamberlain ; Susan M. Poutanen ; Donald E. Low ; Sylvia L. Asa ; Jagdish Butany

Source :

RBID : pubmed:15272286

Descripteurs français

English descriptors

Abstract

The severe acute respiratory syndrome (SARS) pandemic in Toronto resulted in a large number of autopsies on its victims. We describe the pulmonary pathology of patients who died in the 2003 Toronto outbreak. Autopsy material from the lungs of 20 patients who died between March and July 2003 were characterized by histology, molecular biology, and immunohistochemistry for cytokeratins, thyroid transcription factor-1, CD68, Epstein-Barr virus, cytomegalovirus, and human herpes simplex viruses. Matched controls were obtained from patients who died of other causes over the same interval. The mean duration of illness was 27 days (range 5-108 days). Post-mortem lung tissues from 19 of 20 patients with probable SARS were positive for SARS-associated coronavirus by RT-PCR. Histologically, all patients showed varying degrees of exudative and proliferative phase acute lung injury, evidenced in conventional and immunohistochemical stains by edema, inflammatory infiltrate, pneumocyte hyperplasia, fibrinous exudates, and organization. Eight of 20 patients showed predominantly a diffuse alveolar damage pattern of acute lung injury, six showed predominantly an acute fibrinous and organizing pneumonia pattern, and the remainder showed an admixture of the two patterns. Squamous metaplasia and scattered multinucleate giant cells were present in most cases. Vascular fibrin thrombi were a common finding and were often associated with pulmonary infarcts. Special stains demonstrated vascular endothelial damage of both small- and mid-sized pulmonary vessels. Two cases were complicated by invasive fungal disease consistent with Aspergillosis, and another by coinfection with cytomegalovirus. Our findings indicate that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury. Cases of SARS may be complicated by coexistent infections and therapy-related lung injury.

DOI: 10.1038/modpathol.3800247
PubMed: 15272286


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:15272286

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Pulmonary pathology of severe acute respiratory syndrome in Toronto.</title>
<author>
<name sortKey="Hwang, David M" sort="Hwang, David M" uniqKey="Hwang D" first="David M" last="Hwang">David M. Hwang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Toronto Medical Laboratories, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Medical Laboratories, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chamberlain, Dean W" sort="Chamberlain, Dean W" uniqKey="Chamberlain D" first="Dean W" last="Chamberlain">Dean W. Chamberlain</name>
</author>
<author>
<name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
</author>
<author>
<name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name>
</author>
<author>
<name sortKey="Asa, Sylvia L" sort="Asa, Sylvia L" uniqKey="Asa S" first="Sylvia L" last="Asa">Sylvia L. Asa</name>
</author>
<author>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2005">2005</date>
<idno type="RBID">pubmed:15272286</idno>
<idno type="pmid">15272286</idno>
<idno type="doi">10.1038/modpathol.3800247</idno>
<idno type="wicri:Area/PubMed/Corpus">002C49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C49</idno>
<idno type="wicri:Area/PubMed/Curation">002C49</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C49</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002560</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002560</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Pulmonary pathology of severe acute respiratory syndrome in Toronto.</title>
<author>
<name sortKey="Hwang, David M" sort="Hwang, David M" uniqKey="Hwang D" first="David M" last="Hwang">David M. Hwang</name>
<affiliation wicri:level="1">
<nlm:affiliation>Toronto Medical Laboratories, Toronto, Ontario, Canada.</nlm:affiliation>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Toronto Medical Laboratories, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Chamberlain, Dean W" sort="Chamberlain, Dean W" uniqKey="Chamberlain D" first="Dean W" last="Chamberlain">Dean W. Chamberlain</name>
</author>
<author>
<name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
</author>
<author>
<name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name>
</author>
<author>
<name sortKey="Asa, Sylvia L" sort="Asa, Sylvia L" uniqKey="Asa S" first="Sylvia L" last="Asa">Sylvia L. Asa</name>
</author>
<author>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
</author>
</analytic>
<series>
<title level="j">Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</title>
<idno type="ISSN">0893-3952</idno>
<imprint>
<date when="2005" type="published">2005</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Antigens, CD (analysis)</term>
<term>Antigens, Differentiation, Myelomonocytic (analysis)</term>
<term>Aspergillosis (microbiology)</term>
<term>Aspergillosis (pathology)</term>
<term>Aspergillus (growth & development)</term>
<term>Autopsy</term>
<term>Canada</term>
<term>Cytomegalovirus (growth & development)</term>
<term>Cytomegalovirus Infections (pathology)</term>
<term>Cytomegalovirus Infections (virology)</term>
<term>Female</term>
<term>Herpes Simplex (pathology)</term>
<term>Herpes Simplex (virology)</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Keratins (analysis)</term>
<term>Lung (chemistry)</term>
<term>Lung (microbiology)</term>
<term>Lung (pathology)</term>
<term>Lung Diseases, Fungal (microbiology)</term>
<term>Lung Diseases, Fungal (pathology)</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nuclear Proteins (analysis)</term>
<term>RNA, Viral (genetics)</term>
<term>RNA, Viral (isolation & purification)</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>SARS Virus (genetics)</term>
<term>SARS Virus (growth & development)</term>
<term>Severe Acute Respiratory Syndrome (pathology)</term>
<term>Severe Acute Respiratory Syndrome (virology)</term>
<term>Simplexvirus (growth & development)</term>
<term>Thyroid Nuclear Factor 1</term>
<term>Transcription Factors (analysis)</term>
<term>Viral Matrix Proteins (analysis)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>ARN viral (génétique)</term>
<term>ARN viral (isolement et purification)</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Antigènes CD (analyse)</term>
<term>Antigènes de différenciation des myélomonocytes (analyse)</term>
<term>Aspergillose (anatomopathologie)</term>
<term>Aspergillose (microbiologie)</term>
<term>Aspergillus (croissance et développement)</term>
<term>Autopsie</term>
<term>Canada</term>
<term>Cytomegalovirus (croissance et développement)</term>
<term>Facteurs de transcription (analyse)</term>
<term>Femelle</term>
<term>Herpès (anatomopathologie)</term>
<term>Herpès (virologie)</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Infections à cytomégalovirus (anatomopathologie)</term>
<term>Infections à cytomégalovirus (virologie)</term>
<term>Kératines (analyse)</term>
<term>Mycoses pulmonaires (anatomopathologie)</term>
<term>Mycoses pulmonaires (microbiologie)</term>
<term>Mâle</term>
<term>Poumon ()</term>
<term>Poumon (anatomopathologie)</term>
<term>Poumon (microbiologie)</term>
<term>Protéines de la matrice virale (analyse)</term>
<term>Protéines nucléaires (analyse)</term>
<term>RT-PCR</term>
<term>Simplexvirus (croissance et développement)</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
<term>Syndrome respiratoire aigu sévère (anatomopathologie)</term>
<term>Syndrome respiratoire aigu sévère (virologie)</term>
<term>Virus du SRAS (croissance et développement)</term>
<term>Virus du SRAS (génétique)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="analysis" xml:lang="en">
<term>Antigens, CD</term>
<term>Antigens, Differentiation, Myelomonocytic</term>
<term>Keratins</term>
<term>Nuclear Proteins</term>
<term>Transcription Factors</term>
<term>Viral Matrix Proteins</term>
</keywords>
<keywords scheme="MESH" qualifier="analyse" xml:lang="fr">
<term>Antigènes CD</term>
<term>Antigènes de différenciation des myélomonocytes</term>
<term>Facteurs de transcription</term>
<term>Kératines</term>
<term>Protéines de la matrice virale</term>
<term>Protéines nucléaires</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr">
<term>Aspergillose</term>
<term>Herpès</term>
<term>Infections à cytomégalovirus</term>
<term>Mycoses pulmonaires</term>
<term>Poumon</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="chemistry" xml:lang="en">
<term>Lung</term>
</keywords>
<keywords scheme="MESH" qualifier="croissance et développement" xml:lang="fr">
<term>Aspergillus</term>
<term>Cytomegalovirus</term>
<term>Simplexvirus</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>RNA, Viral</term>
<term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="growth & development" xml:lang="en">
<term>Aspergillus</term>
<term>Cytomegalovirus</term>
<term>SARS Virus</term>
<term>Simplexvirus</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>ARN viral</term>
<term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="isolation & purification" xml:lang="en">
<term>RNA, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr">
<term>ARN viral</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiologie" xml:lang="fr">
<term>Aspergillose</term>
<term>Mycoses pulmonaires</term>
<term>Poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="microbiology" xml:lang="en">
<term>Aspergillosis</term>
<term>Lung</term>
<term>Lung Diseases, Fungal</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Aspergillosis</term>
<term>Cytomegalovirus Infections</term>
<term>Herpes Simplex</term>
<term>Lung</term>
<term>Lung Diseases, Fungal</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr">
<term>Herpès</term>
<term>Infections à cytomégalovirus</term>
<term>Syndrome respiratoire aigu sévère</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en">
<term>Cytomegalovirus Infections</term>
<term>Herpes Simplex</term>
<term>Severe Acute Respiratory Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adult</term>
<term>Aged</term>
<term>Aged, 80 and over</term>
<term>Autopsy</term>
<term>Canada</term>
<term>Female</term>
<term>Humans</term>
<term>Immunohistochemistry</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Reverse Transcriptase Polymerase Chain Reaction</term>
<term>Thyroid Nuclear Factor 1</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Autopsie</term>
<term>Canada</term>
<term>Femelle</term>
<term>Humains</term>
<term>Immunohistochimie</term>
<term>Mâle</term>
<term>Poumon</term>
<term>RT-PCR</term>
<term>Sujet âgé</term>
<term>Sujet âgé de 80 ans ou plus</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">The severe acute respiratory syndrome (SARS) pandemic in Toronto resulted in a large number of autopsies on its victims. We describe the pulmonary pathology of patients who died in the 2003 Toronto outbreak. Autopsy material from the lungs of 20 patients who died between March and July 2003 were characterized by histology, molecular biology, and immunohistochemistry for cytokeratins, thyroid transcription factor-1, CD68, Epstein-Barr virus, cytomegalovirus, and human herpes simplex viruses. Matched controls were obtained from patients who died of other causes over the same interval. The mean duration of illness was 27 days (range 5-108 days). Post-mortem lung tissues from 19 of 20 patients with probable SARS were positive for SARS-associated coronavirus by RT-PCR. Histologically, all patients showed varying degrees of exudative and proliferative phase acute lung injury, evidenced in conventional and immunohistochemical stains by edema, inflammatory infiltrate, pneumocyte hyperplasia, fibrinous exudates, and organization. Eight of 20 patients showed predominantly a diffuse alveolar damage pattern of acute lung injury, six showed predominantly an acute fibrinous and organizing pneumonia pattern, and the remainder showed an admixture of the two patterns. Squamous metaplasia and scattered multinucleate giant cells were present in most cases. Vascular fibrin thrombi were a common finding and were often associated with pulmonary infarcts. Special stains demonstrated vascular endothelial damage of both small- and mid-sized pulmonary vessels. Two cases were complicated by invasive fungal disease consistent with Aspergillosis, and another by coinfection with cytomegalovirus. Our findings indicate that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury. Cases of SARS may be complicated by coexistent infections and therapy-related lung injury.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="MEDLINE" Owner="NLM">
<PMID Version="1">15272286</PMID>
<DateCompleted>
<Year>2005</Year>
<Month>07</Month>
<Day>07</Day>
</DateCompleted>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>28</Day>
</DateRevised>
<Article PubModel="Print">
<Journal>
<ISSN IssnType="Print">0893-3952</ISSN>
<JournalIssue CitedMedium="Print">
<Volume>18</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2005</Year>
<Month>Jan</Month>
</PubDate>
</JournalIssue>
<Title>Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc</Title>
<ISOAbbreviation>Mod. Pathol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Pulmonary pathology of severe acute respiratory syndrome in Toronto.</ArticleTitle>
<Pagination>
<MedlinePgn>1-10</MedlinePgn>
</Pagination>
<Abstract>
<AbstractText>The severe acute respiratory syndrome (SARS) pandemic in Toronto resulted in a large number of autopsies on its victims. We describe the pulmonary pathology of patients who died in the 2003 Toronto outbreak. Autopsy material from the lungs of 20 patients who died between March and July 2003 were characterized by histology, molecular biology, and immunohistochemistry for cytokeratins, thyroid transcription factor-1, CD68, Epstein-Barr virus, cytomegalovirus, and human herpes simplex viruses. Matched controls were obtained from patients who died of other causes over the same interval. The mean duration of illness was 27 days (range 5-108 days). Post-mortem lung tissues from 19 of 20 patients with probable SARS were positive for SARS-associated coronavirus by RT-PCR. Histologically, all patients showed varying degrees of exudative and proliferative phase acute lung injury, evidenced in conventional and immunohistochemical stains by edema, inflammatory infiltrate, pneumocyte hyperplasia, fibrinous exudates, and organization. Eight of 20 patients showed predominantly a diffuse alveolar damage pattern of acute lung injury, six showed predominantly an acute fibrinous and organizing pneumonia pattern, and the remainder showed an admixture of the two patterns. Squamous metaplasia and scattered multinucleate giant cells were present in most cases. Vascular fibrin thrombi were a common finding and were often associated with pulmonary infarcts. Special stains demonstrated vascular endothelial damage of both small- and mid-sized pulmonary vessels. Two cases were complicated by invasive fungal disease consistent with Aspergillosis, and another by coinfection with cytomegalovirus. Our findings indicate that the lungs of patients who die of SARS are almost always positive for the SARS-associated coronavirus by RT-PCR, and may show features of both diffuse alveolar damage and acute fibrinous and organizing pneumonia patterns of acute injury. Cases of SARS may be complicated by coexistent infections and therapy-related lung injury.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Hwang</LastName>
<ForeName>David M</ForeName>
<Initials>DM</Initials>
<AffiliationInfo>
<Affiliation>Toronto Medical Laboratories, Toronto, Ontario, Canada.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Chamberlain</LastName>
<ForeName>Dean W</ForeName>
<Initials>DW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Poutanen</LastName>
<ForeName>Susan M</ForeName>
<Initials>SM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Low</LastName>
<ForeName>Donald E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Asa</LastName>
<ForeName>Sylvia L</ForeName>
<Initials>SL</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Butany</LastName>
<ForeName>Jagdish</ForeName>
<Initials>J</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList>
<PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mod Pathol</MedlineTA>
<NlmUniqueID>8806605</NlmUniqueID>
<ISSNLinking>0893-3952</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015703">Antigens, CD</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D015214">Antigens, Differentiation, Myelomonocytic</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C067980">CD68 antigen, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C037662">EBV-associated membrane antigen, Epstein-Barr virus</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="C000614412">NKX2-1 protein, human</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009687">Nuclear Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000074482">Thyroid Nuclear Factor 1</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014157">Transcription Factors</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014763">Viral Matrix Proteins</NameOfSubstance>
</Chemical>
<Chemical>
<RegistryNumber>68238-35-7</RegistryNumber>
<NameOfSubstance UI="D007633">Keratins</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList>
<MeshHeading>
<DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015703" MajorTopicYN="N">Antigens, CD</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D015214" MajorTopicYN="N">Antigens, Differentiation, Myelomonocytic</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001228" MajorTopicYN="N">Aspergillosis</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001230" MajorTopicYN="N">Aspergillus</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D001344" MajorTopicYN="N">Autopsy</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D002170" MajorTopicYN="N">Canada</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003587" MajorTopicYN="N">Cytomegalovirus</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D003586" MajorTopicYN="N">Cytomegalovirus Infections</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006561" MajorTopicYN="N">Herpes Simplex</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007150" MajorTopicYN="N">Immunohistochemistry</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D007633" MajorTopicYN="N">Keratins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008172" MajorTopicYN="N">Lung Diseases, Fungal</DescriptorName>
<QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D009687" MajorTopicYN="N">Nuclear Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D020133" MajorTopicYN="N">Reverse Transcriptase Polymerase Chain Reaction</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
<QualifierName UI="Q000254" MajorTopicYN="Y">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D018139" MajorTopicYN="N">Simplexvirus</DescriptorName>
<QualifierName UI="Q000254" MajorTopicYN="N">growth & development</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D000074482" MajorTopicYN="N">Thyroid Nuclear Factor 1</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014157" MajorTopicYN="N">Transcription Factors</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
<MeshHeading>
<DescriptorName UI="D014763" MajorTopicYN="N">Viral Matrix Proteins</DescriptorName>
<QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="pubmed">
<Year>2004</Year>
<Month>7</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2005</Year>
<Month>7</Month>
<Day>8</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2004</Year>
<Month>7</Month>
<Day>24</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">15272286</ArticleId>
<ArticleId IdType="doi">10.1038/modpathol.3800247</ArticleId>
<ArticleId IdType="pii">3800247</ArticleId>
<ArticleId IdType="pmc">PMC7100506</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 Jul 31;349(5):507-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12890854</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12682352</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pathol. 2003 Jul;200(3):282-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12845623</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1967-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690091</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671061</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Clin Pathol. 2004 Mar;57(3):260-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14990596</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Hum Pathol. 2003 Aug;34(8):743-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14506633</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Pathol Lab Med. 2004 Feb;128(2):195-204</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14736283</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Chin Med J (Engl). 2003 Jul;116(7):976-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12890365</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12711465</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>CMAJ. 2004 Jan 6;170(1):47-54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14707219</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12671062</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Arch Pathol Lab Med. 2002 Sep;126(9):1064-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12204055</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12892955</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12690092</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>JAMA. 2003 Jun 4;289(21):2801-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12734147</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">12781536</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>J Pathol. 2004 Feb;202(2):157-63</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14743497</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList>
<Reference>
<Citation>Emerg Infect Dis. 2004 Jan;10(1):20-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15078592</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Canada</li>
</country>
</list>
<tree>
<noCountry>
<name sortKey="Asa, Sylvia L" sort="Asa, Sylvia L" uniqKey="Asa S" first="Sylvia L" last="Asa">Sylvia L. Asa</name>
<name sortKey="Butany, Jagdish" sort="Butany, Jagdish" uniqKey="Butany J" first="Jagdish" last="Butany">Jagdish Butany</name>
<name sortKey="Chamberlain, Dean W" sort="Chamberlain, Dean W" uniqKey="Chamberlain D" first="Dean W" last="Chamberlain">Dean W. Chamberlain</name>
<name sortKey="Low, Donald E" sort="Low, Donald E" uniqKey="Low D" first="Donald E" last="Low">Donald E. Low</name>
<name sortKey="Poutanen, Susan M" sort="Poutanen, Susan M" uniqKey="Poutanen S" first="Susan M" last="Poutanen">Susan M. Poutanen</name>
</noCountry>
<country name="Canada">
<noRegion>
<name sortKey="Hwang, David M" sort="Hwang, David M" uniqKey="Hwang D" first="David M" last="Hwang">David M. Hwang</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002560 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 002560 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:15272286
   |texte=   Pulmonary pathology of severe acute respiratory syndrome in Toronto.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:15272286" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021